GE HealthCare raises dividend to USD 0.04 per GE HealthCare stock

Published on 10/02/2026 at 14:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue rose 5.70 percent to USD 5.30 billion. GE HealthCare stock costs EUR 57.49 on October 2, 2026 versus EUR 57.13.

Isometrische Illustration zeigt Wertschöpfungskette von Forschung über Produktion bis Patientenversorgung — GE HealthCare US36266G1076 als isometrisches 3D Diagramm der medizintechnischen Wertschöpfungskette von Forschung bis Patient, Illustration mit AI erstellt.

GE HealthCare (ISIN US36266G1076) declared a third-quarter dividend of USD 0.04 per share on September 22, 2026, lifting the payout 14.00 percent from the previous quarter. The dividend gives GE HealthCare stock a fresh capital-return angle while the company works through uneven segment performance.

Dividend rises to USD 0.04

According to GE HealthCare on September 22, 2026, the payment is due on November 13, 2026, to shareholders of record on October 23, 2026. The company previously paid USD 0.035 per share for each of the first two quarters of 2026.

The increase is modest in absolute terms, but it adds a dated shareholder-return event to the stock story. The annualized dividend based on the new quarterly rate is USD 0.16 per share.

Second-quarter demand stays firm

In its second-quarter 2026 report dated July 29, 2026, GE HealthCare reported revenue of USD 5.30 billion, up 5.70 percent year over year. Organic orders grew 11.10 percent, compared with 3.40 percent in the year-ago period, producing a 1.15 times book-to-bill ratio and a USD 23.90 billion backlog.

Adjusted earnings per share reached USD 1.13, while diluted earnings per share came to USD 1.24. The adjusted EBIT margin was 14.20 percent, down from 14.60 percent a year earlier, showing the tension between strong orders and cost pressure.

Analyst target moves above Nasdaq quote

BTIG reiterated a Buy rating and raised its price target from USD 75.00 to USD 79.00 on September 17, 2026, according to Investing.com. The USD 79.00 target lies 23.48 percent above the primary Nasdaq quote of USD 63.98 dated October 1, 2026, based on the same currency.

The operating counterweight is Patient Care Solutions, whose performance the company described as challenged in the second quarter. Full-year 2026 guidance remains organic revenue growth of 3.00 percent to 4.00 percent and adjusted earnings per share of USD 4.80 to USD 5.00.

Euro quote stays above prior close

GE HealthCare was trading at EUR 57.49 at Lang & Schwarz on October 2, 2026 at 2:36 p.m. CEST, plus 0.63 percent versus the prior close of EUR 57.13 on October 1, 2026. The primary Nasdaq quote was last at USD 63.98 on October 1, 2026 at 4:00 p.m. ET, within a 12-month range of USD 58.75 to USD 89.77.

The further course of trading is shown by the continuously updated real-time quote of GE HealthCare stock.